OIG: Medicare May End Up Overpaying for ESRD Drugs



The Office of Inspector General recommends that the Centers for Medicare & Medicaid Services develop "a more accurate method" for estimating changes in the prices of drugs such as those used to treat end-stage renal disease.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.